Tech Company Financing Transactions

Vantage Oncology Funding Round

On 5/10/2005, Vantage Oncology raised $22 million in Series C financing from Conning Capital Partners, New Enterprise Associates and Salix Ventures.

Transaction Overview

Company Name
Announced On
5/10/2005
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series C
Investors

Conning Capital Partners (Lead Investor) (Michael Aspinwall)

New Enterprise Associates (Lead Investor) (Chip Linehan)

Salix Ventures

Versant Ventures

Proceeds Purpose
Vantage Oncology will use the Series C funding to continue acquiring, joint venturing and developing cancer treatment facilities.

Company Information

Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
1500 Rosecrans Avenue 400
Mahattan Beach, CA 90266
USA
Email Address
Overview
Vantage Oncology develops and operates state-of-the-art radiation oncology centers.
Profile
Vantage Oncology LinkedIn Company Profile
Social Media
Vantage Oncology Company Twitter Account
Company News
Vantage Oncology News
Facebook
Vantage Oncology on Facebook
YouTube
Vantage Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Fiore
  Michael Fiore LinkedIn Profile  Michael Fiore Twitter Account  Michael Fiore News  Michael Fiore on Facebook
Chief Financial Officer
Marshal Salomon
  Marshal Salomon LinkedIn Profile  Marshal Salomon Twitter Account  Marshal Salomon News  Marshal Salomon on Facebook
Chief Medical Officer
Leslie Botnick
  Leslie Botnick LinkedIn Profile  Leslie Botnick Twitter Account  Leslie Botnick News  Leslie Botnick on Facebook
Chief Technical Officer
Christopher Rose
  Christopher Rose LinkedIn Profile  Christopher Rose Twitter Account  Christopher Rose News  Christopher Rose on Facebook
Controller
Joe Chang
  Joe Chang LinkedIn Profile  Joe Chang Twitter Account  Joe Chang News  Joe Chang on Facebook
VP - General Counsel
Steve Udicious
  Steve Udicious LinkedIn Profile  Steve Udicious Twitter Account  Steve Udicious News  Steve Udicious on Facebook
VP - Operations
Richard Daversa
  Richard Daversa LinkedIn Profile  Richard Daversa Twitter Account  Richard Daversa News  Richard Daversa on Facebook
VP - Operations
Milton Hinkle
  Milton Hinkle LinkedIn Profile  Milton Hinkle Twitter Account  Milton Hinkle News  Milton Hinkle on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/10/2005: Novariant venture capital transaction
Next: 5/11/2005: Cellerant Therapeutics venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary